Cardiff Oncology, Inc. - CRDF

Sector: Healthcare · Industry: Biological Products, (No Diagnostic Substances)
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q3 2026 · Q2 2026
Value (USD)
Total reported value ($000)
$25.91M
QoQ value delta ($000)
+$753K (+2.99%)
Implied price effect (QoQ)
-0.28%
Shares
Total shares
20,119,554
QoQ shares delta
+639,813 (+3.28%)
Total shares held by funds (by quarter)
Shares (left)

Fund holders include prior positions carried forward until a new 13F confirms a change. Reported holders have reported a position in this security for that quarter; this is not the total number of 13F filers.

Market chart (CRDF)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q3 2026)

Top 25 only Full list
Partial Q3 2026 data: 14 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
Manager Value ($000) Shares % of 13F
Laurion Capital Management LP 4,027 3,098,299 0.1%
VANGUARD CAPITAL MANAGEMENT LLC 3,764 2,895,592 0.0%
PFIZER INC 3,014 2,411,575 1.77%
FRANKLIN RESOURCES INC 1,567 1,205,803 0.0%
BlackRock, Inc. 1,264 972,873 0.0%
BLAIR WILLIAM & CO/IL 1,186 912,513 0.0%
GEODE CAPITAL MANAGEMENT, LLC 1,066 820,062 0.0%
JANE STREET GROUP, LLC 895 688,900 0.0%
GoalVest Advisory LLC 831 687,285 0.14%
UBS Group AG 830 638,699 0.0%
VANGUARD FIDUCIARY TRUST CO 533 410,602 0.0%
GROUP ONE TRADING LLC 528 406,700 0.0%
AQR CAPITAL MANAGEMENT LLC 450 346,353 0.0%
STATE STREET CORP 430 331,395 0.0%
HRT FINANCIAL LP 354 272,786 0.0%
FLPUTNAM INVESTMENT MANAGEMENT CO 321 247,474 0.0%
MORGAN STANLEY 319 246,095 0.0%
BNP PARIBAS FINANCIAL MARKETS 296 228,461 0.0%
X-Square Capital, LLC 267 205,700 0.07%
CITADEL ADVISORS LLC 256 197,400 0.0%
GSA CAPITAL PARTNERS LLP 225 173,274 0.01%
MARSHALL WACE, LLP 210 162,214 0.0%
Bank of New York Mellon Corp 210 161,689 0.0%
NORTHERN TRUST CORP 198 152,875 0.0%
Avestar Capital, LLC 176 136,145 0.01%